Home / Stocks / FN

Fabrinet (FN, Contract electronics makers) Stock Valuation & Fair Value Significantly overvalued

Fabrinet (FN, Contract electronics makers) trades at a current P/E of 32.0, about 102% above its historical normal valuation, with a forward growth estimate of 27.2% and a PEG of 1.18. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 15.8 on the same blended earnings, the 2026-10-09 close of $486.28 corresponds to about $240 a share. This is a valuation reference, not a price target.

Current P/E
32.0
Normal P/E
15.8
PEG
1.18
Fwd growth
27.2%
Div yield
0.0%
RSI (14)
53.5
Neutral
Technical context
  • Price $456.40 at the 2026-10-12 close, 6.1% above the 20-day average ($430.18) and 1.0% above the 50-day ($451.68).
  • RSI (14) at 53.5.
  • 52-week range $374.91 to $746.47: the price is 38.9% below the high and 21.7% above the low.

The Street vs SeerForecast

Wall Street's mean price target for FN is $734.11 across 9 analysts, 60.8% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-14.

Current P/E and rating by weekCurrent P/E moved from 52.4 to 32.0 between 2026-06-12 and 2026-10-09, against a normal P/E of 14.9, with 4 rating changes over 37 recorded weeks.2026-06-12: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-06-142026-06-16: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-06-162026-06-18: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-06-212026-07-02: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-022026-07-06: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-062026-07-09: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-092026-07-10: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-122026-07-13: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-132026-07-14: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-142026-07-20: P/E 52.4, Significantly overvalued, recalculated for the week of 2026-07-202026-07-22: P/E 37.7, Significantly overvalued, recalculated for the week of 2026-07-222026-07-24: P/E 37.7, Significantly overvalued, recalculated for the week of 2026-07-252026-07-27: P/E 37.7, Significantly overvalued, recalculated for the week of 2026-07-272026-07-31: P/E 37.7, Significantly overvalued, recalculated for the week of 2026-07-312026-07-31: P/E 30.9, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 30.9, Favorable on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 39.7, Significantly overvalued, recorded live 2026-08-102026-08-14: P/E 39.7, Significantly overvalued, recalculated for the week of 2026-08-142026-08-14: P/E 40.1, Significantly overvalued, recorded live 2026-08-172026-08-21: P/E 40.1, Significantly overvalued, recalculated for the week of 2026-08-212026-08-21: P/E 29.8, Favorable on our tests, recorded live 2026-08-242026-08-27: P/E 29.8, Favorable on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 29.8, Favorable on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 29.8, Favorable on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 28.1, Favorable on our tests, recorded live 2026-08-312026-09-04: P/E 28.1, Favorable on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 27.5, Favorable on our tests, recorded live 2026-09-072026-09-11: P/E 27.5, Favorable on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 27.8, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 27.8, Favorable on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 25.9, Favorable on our tests, recorded live 2026-09-212026-09-25: P/E 25.9, Favorable on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 27.7, Significantly overvalued, recorded live 2026-09-282026-10-02: P/E 27.7, Significantly overvalued, recalculated for the week of 2026-10-032026-10-02: P/E 30.7, Significantly overvalued, recorded live 2026-10-052026-10-09: P/E 30.7, Significantly overvalued, recalculated for the week of 2026-10-102026-10-09: P/E 32.0, Significantly overvalued, recorded live 2026-10-1220.030.040.050.0Jun 12Jul 12Aug 11Sep 9Oct 9Normal P/E 14.9
Favorable on our testsSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-14P/E 52.4+252%Significantly overvalued (recalculated)
2026-08-03P/E 30.9+108%Favorable on our tests
2026-08-10P/E 39.7+167%Significantly overvalued
2026-08-24P/E 29.8+88%Favorable on our tests
2026-09-21P/E 25.9+64%Favorable on our tests
2026-09-28P/E 27.7+76%Significantly overvalued (across a rating rules change)
2026-10-12P/E 32.0+102%Significantly overvalued ← now
Show all 37 weeks
WeekCurrent P/EPremium to normal P/ERating
2026-06-14P/E 52.4+252%Significantly overvalued (recalculated)
2026-06-16P/E 52.4+252%Significantly overvalued (recalculated)
2026-06-21P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-02P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-06P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-09P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-12P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-13P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-14P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-20P/E 52.4+252%Significantly overvalued (recalculated)
2026-07-22P/E 37.7+153%Significantly overvalued (recalculated)
2026-07-25P/E 37.7+153%Significantly overvalued (recalculated)
2026-07-27P/E 37.7+153%Significantly overvalued (recalculated)
2026-07-31P/E 37.7+153%Significantly overvalued (recalculated)
2026-08-03P/E 30.9+108%Favorable on our tests
2026-08-07P/E 30.9+108%Favorable on our tests (recalculated)
2026-08-10P/E 39.7+167%Significantly overvalued
2026-08-14P/E 39.7+167%Significantly overvalued (recalculated)
2026-08-17P/E 40.1+170%Significantly overvalued
2026-08-21P/E 40.1+170%Significantly overvalued (recalculated)
2026-08-24P/E 29.8+88%Favorable on our tests
2026-08-27P/E 29.8+88%Favorable on our tests (recalculated)
2026-08-28P/E 29.8+88%Favorable on our tests (recalculated)
2026-08-30P/E 29.8+88%Favorable on our tests (recalculated)
2026-08-31P/E 28.1+78%Favorable on our tests
2026-09-05P/E 28.1+78%Favorable on our tests (recalculated)
2026-09-07P/E 27.5+74%Favorable on our tests
2026-09-12P/E 27.5+74%Favorable on our tests (recalculated)
2026-09-14P/E 27.8+76%Favorable on our tests
2026-09-19P/E 27.8+76%Favorable on our tests (recalculated)
2026-09-21P/E 25.9+64%Favorable on our tests
2026-09-26P/E 25.9+64%Favorable on our tests (recalculated)
2026-09-28P/E 27.7+76%Significantly overvalued (across a rating rules change)
2026-10-03P/E 27.7+76%Significantly overvalued (recalculated)
2026-10-05P/E 30.7+94%Significantly overvalued
2026-10-10P/E 30.7+94%Significantly overvalued (recalculated)
2026-10-12P/E 32.0+102%Significantly overvalued ← now

Frequently asked questions

Is Fabrinet stock overvalued?

At a current P/E of 32.0 versus its historical normal P/E of 15.8, Fabrinet trades about 102% above its typical valuation, with a PEG of 1.18 on 27.2% forward growth. tickerseer currently rates it significantly overvalued.

What is Fabrinet's fair value and PEG?

Fabrinet trades at a current P/E of 32.0 against a historical normal P/E of 15.8, a PEG of 1.18, and a forward growth estimate of 27.2%. Priced at its historical normal P/E of 15.8 on the same blended earnings, the 2026-10-09 close of $486.28 corresponds to about $240 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Fabrinet changed?

tickerseer's rating has been significantly overvalued since 2026-06-14.

What is the analyst price target for Fabrinet?

The mean Wall Street price target for Fabrinet is $734.11 across 9 analysts, 60.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Contract electronics makers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.